Skip to content

Treatment of hypersensivity in pacientes with Molar-Incisor Hypomineralization

Hypersensitivity of individuals with molar-incisive hypomineralization - randomized controlled clinical study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-9vk7gt
Enrollment
Unknown
Registered
2018-10-23
Start date
2018-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Molar-incisor hypomineralization (MIH), dentin hypersensitivity, Tooth Demineralization.

Interventions

Participants will be children of both sexes, attending the pediatric dentistry clinic of the Federal University of Piauí (UFPI) who present permanent molars with a diagnosis of molar-incisive hypomine
Drug
C20.543

Sponsors

Universidade federal do Piauí
Lead Sponsor
Universidade federal do Piauí
Collaborator

Eligibility

Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: Volunteers with MIH; with moderate or severe dentin hypersensitivity; from 8 to 12 years; attended at the Children's Clinic of the UFPI Dentistry Course.

Exclusion criteria

Exclusion criteria: Children with special syndrome or need; imperfect amelogenesis; presence of caries in the first permanent molars; who use fixed orthodontic appliance; who present with gingival recession; who have used desensitizers for three months or less who have used analgesics during 8 h prior to treatment.

Design outcomes

Primary

MeasureTime frame
The expected outcome is the reduction of hypersensitivity in patients with MIH. The methods used to evaluate the primary outcome are clinical evaluations and hypersensitivity tests.

Secondary

MeasureTime frame
Better quality of life of children is expected after the treatment of hypersensitivity

Countries

Brazil

Contacts

Public ContactMarina;Renara Natália de Lima;Silva

Universidade federal do Piauí;Universidade federal do Piauí

mdmlima@gmail.com;renaracerqueiras@gmail.com+558632371517 ;+558632371517

Outcome results

None listed

Source: REBEC (via WHO ICTRP)